Approval for the MagtraceTM and Sentimag Magnetic Localization System.  The MagtraceTM and Sentimag Magnetic Localization System is indicated to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy. MagtraceTM is intended and calibrated for use ONLY with the Sentimag system.